Honzawa Yusuke, Matsuura Minoru, Higuchi Hirokazu, Sakurai Takaki, Seno Hiroshi, Nakase Hiroshi
Department of Gastroenterology and Hepatology, Kyoto University Hospital, Kyoto, Japan.
Department of Medical Supply, Kyoto University Hospital, Kyoto, Japan.
Endosc Int Open. 2020 Jan;8(1):E41-E49. doi: 10.1055/a-0990-9375. Epub 2020 Jan 8.
Mucosal healing (MH) is associated with clinical outcome in ulcerative colitis (UC) patients. In most clinical trials, a Mayo endoscopic subscore (MES) of 0 or 1 is defined as MH. However, several recent studies have reported that clinical outcome is different between UC patients with MES 0 and those with MES 1. In addition, the MES is subjective and may differ among endoscopists. Therefore, a repeatable and objective scoring system is required to distinguish MES 0 from MES 1, even in clinically quiescent UC. Here, we assessed the usefulness of new image-enhancing endoscopic technology, the i-scan TE-c, to quantitatively evaluate colonic inflammation in patients with quiescent UC. We retrospectively reviewed the data from 52 UC patients in clinical remission who had undergone routine colonoscopy with standard white light. The white-light images were reassessed using the new system, and the degree of colonic mucosal inflammation was quantified according to the MAGIC (Mucosal Analysis of Inflammatory Gravity by i-scan TE-c Image) score. We used the i-scan TE-c system to investigate the association among the MAGIC score, MES, and histologic activity (Geboes score). The MAGIC score was significantly higher in the MES 1 group than in the MES 0 group ( = 0.0034). The MAGIC score significantly correlated with the Geboes score ( = 0.015). Our novel image-enhancing endoscopic system was useful for objective and quantitative evaluation of MH in patients with quiescent UC. Further clinical studies using this imaging system are required to confirm its clinical benefit for the management of UC patients.
黏膜愈合(MH)与溃疡性结肠炎(UC)患者的临床结局相关。在大多数临床试验中,梅奥内镜亚评分(MES)为0或1被定义为黏膜愈合。然而,最近的几项研究报告称,MES为0的UC患者与MES为1的患者的临床结局有所不同。此外,MES具有主观性,不同内镜医师之间可能存在差异。因此,即使在临床静止期的UC患者中,也需要一种可重复且客观的评分系统来区分MES 0和MES 1。在此,我们评估了新型图像增强内镜技术i-scan TE-c对定量评估静止期UC患者结肠炎症的有用性。我们回顾性分析了52例临床缓解期UC患者的常规白光结肠镜检查数据。使用新系统重新评估白光图像,并根据MAGIC(通过i-scan TE-c图像进行炎症严重程度的黏膜分析)评分对结肠黏膜炎症程度进行量化。我们使用i-scan TE-c系统研究MAGIC评分、MES和组织学活性(Geboes评分)之间的关联。MES 1组的MAGIC评分显著高于MES 0组(P = 0.0034)。MAGIC评分与Geboes评分显著相关(P = 0.015)。我们的新型图像增强内镜系统有助于对静止期UC患者的黏膜愈合进行客观和定量评估。需要使用该成像系统进行进一步的临床研究,以证实其对UC患者管理的临床益处。